These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


123 related items for PubMed ID: 11472876

  • 1. The parkinsonian neurotoxin, MPP+ induces phosphorylated c-Jun in dopaminergric neurons of mesencephalic cultures.
    Gearan T, Castillo OA, Schwarzschild MA.
    Parkinsonism Relat Disord; 2001 Sep; 8(1):19-22. PubMed ID: 11472876
    [Abstract] [Full Text] [Related]

  • 2. FGF-2-mediated protection of cultured mesencephalic dopaminergic neurons against MPTP and MPP+: specificity and impact of culture conditions, non-dopaminergic neurons, and astroglial cells.
    Otto D, Unsicker K.
    J Neurosci Res; 1993 Mar 01; 34(4):382-93. PubMed ID: 8097265
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Parkinsonian mimetics induce aspects of unfolded protein response in death of dopaminergic neurons.
    Holtz WA, O'Malley KL.
    J Biol Chem; 2003 May 23; 278(21):19367-77. PubMed ID: 12598533
    [Abstract] [Full Text] [Related]

  • 8. Functional changes in cocultures of mesencephalon and striatal neurons from embryonic C57/BL6 mice due to low concentrations of 1-methyl-4-phenylpyridinium (MPP+).
    Koutsilieri E, Chan WW, Reinitzer D, Rausch WD.
    J Neural Transm Gen Sect; 1993 May 23; 94(3):189-97. PubMed ID: 7907217
    [Abstract] [Full Text] [Related]

  • 9. Expression of c-Jun in dopaminergic neurons of the substantia nigra in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice.
    Nishi K.
    Brain Res; 1997 Oct 10; 771(1):133-41. PubMed ID: 9383016
    [Abstract] [Full Text] [Related]

  • 10. Caspase-dependent and -independent cell death pathways in primary cultures of mesencephalic dopaminergic neurons after neurotoxin treatment.
    Han BS, Hong HS, Choi WS, Markelonis GJ, Oh TH, Oh YJ.
    J Neurosci; 2003 Jun 15; 23(12):5069-78. PubMed ID: 12832530
    [Abstract] [Full Text] [Related]

  • 11. Response to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) differs in mouse strains and reveals a divergence in JNK signaling and COX-2 induction prior to loss of neurons in the substantia nigra pars compacta.
    Boyd JD, Jang H, Shepherd KR, Faherty C, Slack S, Jiao Y, Smeyne RJ.
    Brain Res; 2007 Oct 17; 1175():107-16. PubMed ID: 17884023
    [Abstract] [Full Text] [Related]

  • 12. JNK inhibitor protects dopaminergic neurons by reducing COX-2 expression in the MPTP mouse model of subacute Parkinson's disease.
    Wang Y, Zhang Y, Wei Z, Li H, Zhou H, Zhang Z, Zhang Z.
    J Neurol Sci; 2009 Oct 15; 285(1-2):172-7. PubMed ID: 19604516
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. JNK-mediated activation of ATF2 contributes to dopaminergic neurodegeneration in the MPTP mouse model of Parkinson's disease.
    Huang Q, Du X, He X, Yu Q, Hu K, Breitwieser W, Shen Q, Ma S, Li M.
    Exp Neurol; 2016 Mar 15; 277():296-304. PubMed ID: 26515688
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The glutamate antagonist, MK-801, does not prevent dopaminergic cell death induced by the 1-methyl-4-phenylpyridinium ion (MPP+) in rat dissociated mesencephalic cultures.
    Michel PP, Agid Y.
    Brain Res; 1992 Dec 04; 597(2):233-40. PubMed ID: 1361874
    [Abstract] [Full Text] [Related]

  • 20. Blockade of the translocation and activation of c-Jun N-terminal kinase 3 (JNK3) attenuates dopaminergic neuronal damage in mouse model of Parkinson's disease.
    Pan J, Xiao Q, Sheng CY, Hong Z, Yang HQ, Wang G, Ding JQ, Chen SD.
    Neurochem Int; 2009 Jun 04; 54(7):418-25. PubMed ID: 19428783
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.